MiR-509-3p is oncogenic, targets the tumor suppressor PHLPP2, and functions as a novel tumor adjacent normal tissue based prognostic biomarker in colorectal cancer.
Deepak Narayanan IyerDominic Chi-Chung FooOswens Siu-Hung LoTimothy Ming-Hun WanXue LiRyan Wai-Yan SinRoberta Wen-Chi PangWai-Lun LawLui NgPublished in: BMC cancer (2022)
MiR-509-3p strongly contributes to the development and progression of CRC and can potentially function as a prognostic biomarker in the disease.
Keyphrases